Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Heinig
Regorafenib (BAY 73-4506) in Advanced Colorectal Cancer: A Phase I Study
British Journal of Cancer
Cancer Research
Oncology
Related publications
Regorafenib Okayed for Colorectal Cancer
Cancer Discovery
Oncology
Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer
Investigational New Drugs
Oncology
Pharmacology
Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase I Study of Telatinib (BAY 57-9352): Analysis of Safety, Pharmacokinetics, Tumor Efficacy, and Biomarkers in Patients With Colorectal Cancer
Vascular Cell
Computer Networks
Developmental Neuroscience
Neurology
Cell Biology
Communications
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Long‐term Survival of an Advanced Colorectal Cancer Patient Treated With Regorafenib: Case Report and Literature Review
Clinical Case Reports
Medicine
A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology